Profiling a new VITT-like disorder; real-world outcomes of tafasitamab and lenalidomide in LBCL; and spatial mapping of human hematopoiesis
This Blood Podcast episode discusses a new disorder resembling VITT, reviews real-world outcomes for large B-cell lymphoma patients treated with tafasitamab and lenalidomide, and covers technological advancements in mapping human hematopoiesis.